KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Total Current Liabilities: 2010-2024

Historic Total Current Liabilities for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $5.2 million.

  • TherapeuticsMD's Total Current Liabilities fell 17.25% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 17.25%. This contributed to the annual value of $5.2 million for FY2024, which is 24.63% down from last year.
  • According to the latest figures from FY2024, TherapeuticsMD's Total Current Liabilities is $5.2 million, which was down 24.63% from $6.9 million recorded in FY2023.
  • TherapeuticsMD's Total Current Liabilities' 5-year high stood at $252.9 million during FY2021, with a 5-year trough of $5.2 million in FY2024.
  • Over the past 3 years, TherapeuticsMD's median Total Current Liabilities value was $6.9 million (recorded in 2023), while the average stood at $19.6 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first spiked by 326.91% in 2021, then tumbled by 85.37% in 2023.
  • TherapeuticsMD's Total Current Liabilities (Yearly) stood at $59.2 million in 2020, then soared by 326.91% to $252.9 million in 2021, then slumped by 81.48% to $46.8 million in 2022, then crashed by 85.37% to $6.9 million in 2023, then decreased by 24.63% to $5.2 million in 2024.